GreenLite Secures $28.5 Million in Series A Funding to Revolutionize Construction Permitting

In a groundbreaking initiative aimed at revolutionizing construction permitting, GreenLite has successfully closed a Series A funding round, raising $28.5 million. This funding, led by Craft Ventures and supported by 53 Stations, Trust Ventures, and LiveOak Ventures, will empower GreenLite to enhance its technology platform and expand its innovative Private Plan Review service. Launched in…

Read More

AIRS Medical Secures $20M in Series C Funding to Expand AI-Powered Healthcare Solutions

AIRS Medical, a trailblazer in artificial intelligence (AI) and robotics for healthcare applications, has announced a significant milestone with the closing of its Series C funding round, securing $20 million from leading institutional investors in South Korea. BSK Investment and Shinyoung Securities led the investment, underscoring confidence in AIRS Medical’s pioneering efforts to revolutionize preventive…

Read More

Xposure Music Secures $42.5M to Empower Independent Artists and Scale Catalog Investments

In an era where independent musicians often face capital constraints, Xposure Music has raised $42.5 million USD in debt and equity financing, bringing the company’s total funding past $50 million USD. The round includes debt financing from Andalusian Credit Partners and equity participation from select family offices and private investors, positioning the Montreal-based startup to…

Read More

Jade Biosciences Secures $80 Million Funding to Advance Breakthrough Therapies for Autoimmune Diseases

Jade Biosciences, a biotechnology innovator focused on autoimmune diseases, has announced the successful closing of an $80 million financing round. Led by Fairmount and Venrock Healthcare Capital Partners, with additional contributions from Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, and Braidwell LP, this investment will drive the development of Jade’s cutting-edge therapies…

Read More
LtoR-Chief Technical Officer & Co-founder, Rafael Fietzek and Chief Executive Officer & co-founder Stéphane Foulard.

COMPREDICT Secures $15M Series B Funding to Propel Automotive Innovation

In a strategic move poised to revolutionize the automotive industry, COMPREDICT, a leader in AI-powered solutions for software-defined vehicles, has announced a significant milestone with a $15 million Series B funding round. This round was led by Woven Capital, Toyota’s growth fund, marking a pivotal moment in COMPREDICT’s journey to redefine vehicle functionality through advanced…

Read More

DinMo Secures €5 Million to Enhance Composable Customer Data Platform

In a significant move poised to reshape the landscape of customer data management, DinMo, a Paris-based Data Activation company, has successfully raised €5 million in funding. This investment will accelerate the development of its innovative Composable Customer Data Platform (CDP), aimed specifically at empowering mid-market businesses to leverage their customer data without the need for…

Read More

Leya Raises $25 Million to Expand AI-Driven Legal Solutions, Led by Redpoint Ventures

Leya, a pioneering force in AI-driven legal technology, has successfully concluded its Series A funding round with a significant $25 million investment. The round was spearheaded by Redpoint Ventures, accompanied by strong support from existing investors Benchmark, Y Combinator, and Wayfinder Ventures, alongside new addition Alt Capital. Founded on the fundamental belief that legal professionals…

Read More

Neuspera Medical Secures $23 Million to Advance Minimally Invasive Treatment for Overactive Bladder

Neuspera Medical, a company pioneering a discreet and minimally invasive treatment for overactive bladder (OAB), has secured $23 million in Series D financing. This significant investment round, led by Vertex Ventures HC and Treo Ventures, will propel Neuspera’s Neuspera System through U.S. Food and Drug Administration (FDA) premarket approval (PMA) and towards commercialization. OAB, a…

Read More

Spear Bio Secures $45 Million in Oversubscribed Series A Round to Revolutionize Protein Research and Diagnostics

Spear Bio Inc., an innovative biotechnology company specializing in ultra-sensitive protein detection, has successfully closed an oversubscribed $45 million Series A financing round. The investment was co-led by Foresite Capital and Bio-Techne Corporation, with additional support from Maverick Ventures, Yonjin Capital, and CDH Investments. Vikram Bajaj, Managing Director at Foresite Capital, will join Spear Bio’s…

Read More
CEO Michael Yamartino Source: NYSE youtube

Route Secures $40 Million Series C Funding, Valued at $1.4 Billion, Pioneering Post-Purchase Revolution

Route, the forefront innovator in post-purchase solutions, has announced a significant milestone today with the closing of a $40 million Series C funding round, elevating its valuation to an impressive $1.4 billion. The financing, led by Hanaco VC and bolstered by JAWS Ventures, Madrona Ventures, and Granger, underscores Route’s pivotal role in reshaping the global…

Read More